Stage Stores (SSI) Reports In-Line Q2 EPS; Guides Q3 Below Views; FY11 In-Line
Get Alerts SSI Hot Sheet
Price: $0.38 --0%
Financial Fact:
Selling, general and administrative expenses: 84.56M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, general and administrative expenses: 84.56M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Stage Stores, Inc. (NYSE: SSI) reported Q2 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $352.83 million versus the consensus estimate of $354.48 million.
Stage sees an increase in comparable store sales of between 1.0% and 3.0% for the third and fourth quarters.
Sees Q3 2011 loss of ($0.24) - ($0.21), versus the consensus of ($0.19). Stage Stores, Inc. sees Q3 2011 revenue of $340-$346 million, versus the consensus of $346.83 million.
Stage Stores, Inc. sees FY2011 EPS of $1.10-$1.16, versus the consensus of $1.10. Stage Stores, Inc. sees FY2011 revenue of $1.507-$1.523 billion, versus the consensus of $1.52 billion.
Stage sees an increase in comparable store sales of between 1.0% and 3.0% for the third and fourth quarters.
Sees Q3 2011 loss of ($0.24) - ($0.21), versus the consensus of ($0.19). Stage Stores, Inc. sees Q3 2011 revenue of $340-$346 million, versus the consensus of $346.83 million.
Stage Stores, Inc. sees FY2011 EPS of $1.10-$1.16, versus the consensus of $1.10. Stage Stores, Inc. sees FY2011 revenue of $1.507-$1.523 billion, versus the consensus of $1.52 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share